Socioeconomic Factors and Survival of Multiple Myeloma Patients

SIMPLE SUMMARY: Multiple Myeloma is the third most common hematologic malignancy. Outcomes have improved significantly, as the result of the introduction of novel agents as well as higher utilization of autologous Hematopoietic Cell Transplant. These complex treatment regimens are quite expensive an...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancers (Basel)
Glavni autori: Chamoun, Kamal, Firoozmand, Amin, Caimi, Paolo, Fu, Pingfu, Cao, Shufen, Otegbeye, Folashade, Metheny, Leland, Patel, Seema, Gerson, Stanton L., Boughan, Kirsten, De Lima, Marcos, Malek, Ehsan
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2021
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7913279/
https://ncbi.nlm.nih.gov/pubmed/33546206
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13040590
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items